Review of the Rationale for Strategic Shareholdings and Consideration of Reductions
First written in FY2019. 4 of 8 entries say "Advanced", first in FY2021. Latest entry: FY2026.
- FY2026AchievedAnnual report
「During the fiscal year, 1 issue was sold, completing the sale of all holdings.」
Under the policy of selling all strategic shareholdings other than unlisted shares, the sale of the final 1 issue was completed, bringing the implementation phase to an end. - FY2025AdvancedAnnual report
「During the fiscal year, sales were completed for all but 1 issue. The sale of that remaining issue is also scheduled to be completed in July 2025.」
Strategic shareholdings declined from 25 issues and ¥994 million in the fiscal year ended March 2024 to 11 issues and ¥76 million. Implementation of the policy to sell all holdings other than unlisted shares entered its final stage. - FY2024RaisedAnnual report
「At a Board of Directors meeting held on 23 October 2023, the company resolved to proceed with the sale of all strategic shareholdings currently held during fiscal 2024.」
The scope and target for strategic shareholdings were expanded from phased reductions to a policy of selling all holdings during fiscal 2024. The number of holdings declined to 25, with a carrying amount of ¥994 million. - FY2023AdvancedAnnual report
「As a result of the review, including the verification by the Board of Directors, the number of holdings and the carrying amount have been reduced in stages, as shown in the table below. Fiscal year ended March 2019: 40 issues, ¥2,902 million; fiscal year ended March 2023: 31 issues, ¥1,622 million」
Strategic shareholdings were reduced further, from 34 issues and ¥1,673 million to 31 issues and ¥1,622 million. - FY2022AdvancedAnnual report
「As a result of the review, including the verification by the Board of Directors, the number of holdings and the carrying amount have been reduced in stages, as shown in the table below. Fiscal year ended March 2018: 41 issues, ¥3,475 million Fiscal year ended March 2022: 34 issues, ¥1,673 million」
Strategic shareholdings declined further, from 36 issues to 34 issues and from ¥1,953 million to ¥1,673 million on the balance sheet. - FY2021AdvancedAnnual report
「As a result of the review, including the verification by the Board of Directors, the number of holdings and the carrying amount have been reduced in stages, as shown in the table below.」
Strategic shareholdings declined in stages from 41 issues in the fiscal year ended March 2017 to 36 issues in the fiscal year ended March 2021, while the amount recognised on the balance sheet fell from ¥3,517 million to ¥1,953 million. - FY2020RestatedAnnual report
「Once a year, the Board of Directors verifies whether strategic shareholdings are consistent with their intended purpose and whether the benefits and risks associated with holding them are commensurate with the cost of capital, among other indicators, to assess whether they should be retained.」
The company continues to conduct an annual Board of Directors review of strategic shareholdings and to consider reductions where there is no rational basis for holding them. - FY2019First statedAnnual report
「Once a year, the Board of Directors verifies whether strategic shareholdings are consistent with their intended purpose and whether the benefits and risks associated with holding them are commensurate with the cost of capital, among other indicators, to assess whether they should be retained.」
For strategic shareholdings, the company outlined an annual review by the Board of Directors and a policy of considering reductions where there is no rational basis for holding them.